高危直肠癌术前短程质子与光子放疗比较(PRORECT):初步剂量学经验
PRORECT随机II期试验的初步剂量学分析,纳入2021年6月至2022年6月连续20例局部晚期直肠癌患者,为每例患者分别生成VMAT光子计划和质子束治疗计划并进行配对比较。质子短程放疗较光子显著降低膀胱、骨骼和肠道等盆腔危及器官的照射剂量,两者适形性和均匀性指数相当。
要点
- 质子短程放疗较光子显著降低膀胱、骨骼和肠道等盆腔危及器官剂量。
- 光子与质子计划的适形性和均匀性指数相当。
- 剂量学优势能否转化为临床获益将由PRORECT后续报告呈现。
核心结论
- 术前质子短程放疗较当前光子放疗技术显著降低正常组织照射剂量。
- 所显示的剂量学优势可能在局部晚期直肠癌患者中转化为可测量的临床获益。
研究设计与样本
- 随机II期试验PRORECT(NCT04525989)的初步剂量学比较研究。
- 2021年6月至2022年6月连续纳入20例局部晚期直肠癌患者并按研究方案治疗。
- 为每例患者分别生成VMAT光子和质子束治疗计划并进行配对比较。
主要发现
- 剂量体积直方图分析显示质子短程放疗较光子显著降低膀胱、骨骼和肠道等盆腔危及器官的照射剂量。
- 光子与质子治疗计划的适形性和均匀性指数相当。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Neoadjuvant short-course radiotherapy (SCRT) followed by full-dose systemic chemotherapy is an established treatment modality in locally advanced rectal cancer (LARC). Until recently, SCRT has been exclusively delivered with photons. Proton beam therapy (PBT) may minimize acute toxicity, which in turn likely impacts favorably on the tolerability to subsequent chemotherapy. The aim of this study is a dosimetric comparison between SCRT with photons and protons in the randomized phase II trial PRORECT (NCT04525989). MATERIALS AND METHODS: From June 2021 to June 2022, twenty consecutive patients with LARC have been treated according to study protocol. For each patient, both a VMAT and a PBT treatment plans have been generated and compared pairwise. RESULTS: Dose-volume histogram (DVH) analysis revealed that SCRT with protons significantly reduced radiation dose to pelvic organs at risk including bladder, bones, and bowel in comparison to SCRT with photons. Photon and proton treatment plans had equivalent conformity and homogeneity indexes. CONCLUSION: Preoperative SCRT with protons offers a significant reduction of radiation dose to normal tissues compared with current photon-based radiotherapy technique. Demonstrated dosimetric advantages may translate into measurable clinical benefits in patients with LARC. Clinical implications of the dosimetric superiority of SCRT with protons will be presented in the coming reports from the PRORECT trial.
引用
- Pedone C, Sorcini B, Staff C, et al. Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience. Clin Transl Radiat Oncol. 2022. PMID: 36582423. doi:10.1016/j.ctro.2022.100562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。